𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recent Advances in the Development of Dopamine D3 Receptor Antagonists: a Medicinal Chemistry Perspective

✍ Scribed by Dr. Fabrizio Micheli

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
804 KB
Volume
6
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Dopamine (DA) D~3~ receptor antagonism might play a significant role in different therapeutic areas. A high number of preclinical studies on DA D~3~ receptor antagonists have shown efficacy in animal models of Parkinson’s disease, schizophrenia and drug dependence. This Review covers the activities of medicinal chemists in this field over the last ten years towards the identification of truly selective compounds. Both primary and patent literature is reviewed here. Since the original discoveries, a clear trend towards the optimization of the developability properties of the new scaffold has clearly emerged with time, from both academic and industrial researchers. Examples of advanced leads from academia and industry are described. The latest potential therapeutic applications are reported too.

πŸ“œ SIMILAR VOLUMES

Recent developments in the field of A3 a
Recent developments in the field of A3 adenosine receptor antagonists
✍ Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Andrea Bo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

## Abstract Adenosine is an endogenous modulator of a large variety of physiological functions through the interaction with specific cell membrane G‐protein‐coupled receptors classified as A~1~, A~2A~, A~2B~, and A~3~. Activation of A~3~ receptors has been shown to stimulate phospholipase C and to